Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chitosan Oligosaccharides Alleviate Heat-Stress-Induced Lipid Metabolism Disorders by Suppressing the Oxidative Stress and Inflammatory Response in the Liver of Broilers. | Antioxidants (Basel) | 2023 | 37627493 | PubTator, text mining | PubMed |
| CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease. | Hepatobiliary Surg Nutr | 2023 | 37600998 | PubTator, text mining | PubMed |
| Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol. | J Clin Med | 2023 | 37568484 | PubTator, text mining | PubMed |
| New Biological Therapies for Low-Density Lipoprotein Cholesterol. | Can J Cardiol | 2023 | 37562541 | PubTator, text mining | PubMed |
| High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism. | J Lipid Res | 2023 | 37558128 | PubTator, text mining | PubMed |
| Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures. | Nat Commun | 2023 | 37532704 | PubTator, text mining | PubMed |
| Editorial: Rare dyslipidemias. | Front Genet | 2023 | 37529775 | PubTator, text mining | PubMed |
| NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences. | Biomedicines | 2023 | 37509601 | PubTator, text mining | PubMed |
| Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review. | Brain Sci | 2023 | 37508912 | PubTator, text mining | PubMed |
| Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. | J Transl Med | 2023 | 37507803 | PubTator, text mining | PubMed |
| Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention. | Am J Cardiovasc Drugs | 2023 | 37486464 | PubTator, text mining | PubMed |
| Identification and characterisation of a rare MTTP variant underlying hereditary non-alcoholic fatty liver disease. | JHEP Rep | 2023 | 37484212 | PubTator, text mining | PubMed |
| Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients. | Eur J Med Res | 2023 | 37480146 | PubTator, text mining | PubMed |
| Dissecting peri-implantation development using cultured human embryos and embryo-like assembloids. | Cell Res | 2023 | 37460804 | PubTator, text mining | PubMed |
| Bean Leaves Ameliorate Lipotoxicity in Fatty Liver Disease. | Nutrients | 2023 | 37447254 | PubTator, text mining | PubMed |
| Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention. | Nutrients | 2023 | 37447172 | PubTator, text mining | PubMed |
| Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux. | J Clin Med | 2023 | 37445434 | PubTator, text mining | PubMed |
| Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. | Adv Sci (Weinh) | 2023 | 37436087 | PubTator, text mining | PubMed |
| Molecular targets of spermidine: implications for cancer suppression. | Cell Stress | 2023 | 37431488 | PubTator, text mining | PubMed |
| Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention. | Nutr Metab (Lond) | 2023 | 37415199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=11